Conatus Pharmaceuticals Inc. (57) | Business Finance (21)
Browse by Subcategory
Recent Contracts
-
Form of Securities Purchase Agreement
(Filed With SEC on December 29, 2020)
-
Form of pre-funded warrant
(Filed With SEC on December 29, 2020)
-
Specimen Common Stock Certificate
(Filed With SEC on August 13, 2020)
-
Registration Rights Agreement, dated as of July 20, 2020, by and between the Company and Lincoln Park
(Filed With SEC on July 20, 2020)
-
Amended and Restated Release, dated January 28, 2020, by and among Histogen Inc., Jonathan Jackson, Lordship Ventures LLC, and Lordship Ventures Histogen Holdings LLC
(Filed With SEC on February 7, 2020)
-
Form of placement agents warrant
(Filed With SEC on December 29, 2020)
-
Form of Common Warrant
(Filed With SEC on December 29, 2020)
-
Form of Securities Purchase Agreement
(Filed With SEC on November 12, 2020)
-
Form of Placement Agent Warrant
(Filed With SEC on November 12, 2020)
-
Form of Warrant
(Filed With SEC on November 12, 2020)
-
Purchase Agreement, dated as of July 20, 2020, by and between the Company and Lincoln Park
(Filed With SEC on July 20, 2020)
-
Description of Capital Stock
(Filed With SEC on March 11, 2020)
-
Notice of Grant of Stock Option, dated January 24, 2019, by and between Histogen Inc. and Richard W. Pascoe
(Filed With SEC on February 7, 2020)
-
Histogen Inc. Form of Stock Option Agreement (2007 Stock Plan)
(Filed With SEC on February 7, 2020)
-
Histogen Inc. 2007 Stock Plan
(Filed With SEC on February 7, 2020)
-
Histogen Inc. Form of Stock Option Agreement (2017 Stock Plan)
(Filed With SEC on February 7, 2020)
-
Histogen Inc. 2017 Stock Plan
(Filed With SEC on February 7, 2020)
-
Histogen Inc. Form of Warrant
(Filed With SEC on February 7, 2020)
-
General Release of Claims, dated July 1, 2019, by and between Daniel L. Ripley and the Registrant
(Filed With SEC on November 5, 2019)
-
General Release of Claims, dated October 1, 2019, by and between David T. Hagerty, M.D. and the Registrant
(Filed With SEC on November 5, 2019)
-
General Release of Claims, dated July 1, 2019, by and between Edward F. Smith, III, Ph.D. and the Registrant
(Filed With SEC on November 5, 2019)